venom, culture, genetics & genomics
Phase 3 Win for Gene Therapy
Phase 3 Win for Gene Therapy
Kerry Grens | Oct 6, 2015
The treatment restored sight among people with an inherited visual impairment.
Debating the Value of Anonymity
Debating the Value of Anonymity
Jef Akst | Oct 5, 2015
PubPeer responds to criticism that anonymous post-publication peer review threatens the scientific process.
Gene-Edited Pets
Gene-Edited Pets
Karen Zusi | Oct 2, 2015
Genomics giant BGI announces plans to sell “micro-pigs” it originally developed for research.
New Way to Edit Genes
New Way to Edit Genes
Jef Akst | Oct 1, 2015
Researchers develop a more-efficient method for rewriting DNA that could hold therapeutic value for HIV and other diseases.
Decon Recon
Decon Recon
Sarah C.P. Williams | Oct 1, 2015
Published genomes are chock-full of contamination. But as awareness of the problem grows, so do methods to help combat it.
Ready, Willing, and Able
Ready, Willing, and Able
Amanda B. Keener | Oct 1, 2015
Researchers with disabilities are making their fields more accessible.
Lefties, Language, and Lateralization
Lefties, Language, and Lateralization
Bob Grant | Oct 1, 2015
The long-sought genetic link between handedness and language lateralization patterns in the brain is turning out to be illusory.
CRISPR 2.0?
CRISPR 2.0?
Jef Akst | Sep 28, 2015
A pioneer of the gene-editing technique discovers a protein that could improve its accuracy.
Local Microbes Give Wine Character
Local Microbes Give Wine Character
Ruth Williams | Sep 24, 2015
Yeast strains from different regions of New Zealand generate wines with varying chemistries.
Venter Enters the Consumer Genomics Biz
Venter Enters the Consumer Genomics Biz
Bob Grant | Sep 22, 2015
The genomic entrepreneur has struck a deal with a South African health insurer to sequence the exomes of its customers.